The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Angiogenesis polymorphisms profile in the prediction of clinical outcome of advanced HCC patients receiving sorafenib: Combined analysis of VEGF and HIF-1.
Luca Faloppi
No relevant relationships to disclose
Mario Scartozzi
No relevant relationships to disclose
Marco D'Anzeo
No relevant relationships to disclose
Maristella Bianconi
No relevant relationships to disclose
Gianluca Svegliati Baroni
No relevant relationships to disclose
Nicola Silvestris
No relevant relationships to disclose
Andrea Casadei Gardini
No relevant relationships to disclose
Gianluca Masi
No relevant relationships to disclose
Riccardo Giampieri
No relevant relationships to disclose
Michela Del Prete
No relevant relationships to disclose
Samuele De Minicis
No relevant relationships to disclose
Alessandra Mandolesi
No relevant relationships to disclose
Antonio Benedetti
No relevant relationships to disclose
Stefano Cascinu
No relevant relationships to disclose